Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001493152-24-046020
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$941.00K | -$1.92M | -$1.22M | -$509.30K |
| EPS Diluted | -$14.21 | -$4.90 | -$3.53 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
